Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-10 4:05 pm Sale | 13G | PolyPid Ltd. PYPD | Gabriel Capital Management Ltd. | 447,909 2.300% | -659,511 (-59.55%) | View |
2022-02-10 4:02 pm Purchase | 13G | CHEMOMAB THERAPEUTICS LTD CMMB | Gabriel Capital Management Ltd. | 3,087,040 1.400% | 3,087,040 (New Position) | View |
2022-02-10 4:00 pm Sale | 13G | PolyPid Ltd. PYPD | Gabriel Capital Management Ltd. | 1,107,420 5.900% | -130,746 (-10.56%) | View |
2021-02-12 4:31 pm Sale | 13G | GAMIDA CELL LTD GMDAQ | Gabriel Capital Management Ltd. | 467,809 0.800% | -1,690,284 (-78.32%) | View |
2021-02-12 4:30 pm Purchase | 13G | PolyPid Ltd. PYPD | Gabriel Capital Management Ltd. | 1,238,166 6.700% | 1,238,166 (New Position) | View |
2020-02-14 4:26 pm Sale | 13G | GAMIDA CELL LTD GMDAQ | Gabriel Capital Management Ltd. | 2,158,093 6.300% | -582,593 (-21.26%) | View |
2020-01-02 4:00 pm Purchase | 13G | CHEMOMAB THERAPEUTICS LTD CMMB | Gabriel Capital Management Ltd. | 8,868,546 21.700% | 8,868,546 (New Position) | View |